Detalhe da pesquisa
1.
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Lancet;
397(10269): 119-127, 2021 01 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33422245
2.
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
AIDS Res Ther;
14: 26, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28484508
3.
The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis.
AIDS Res Ther;
13(1): 28, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27582777
4.
Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008.
Trop Med Int Health;
17(8): e49-57, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22943379
5.
Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa.
Trop Med Int Health;
17(8): e38-48, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22943378
6.
Effects of the Pratt pouch model of dispensing nevirapine prophylaxis on HIV exposed infant completion of 6 weeks of prophylaxis in Uganda.
PLoS One;
16(3): e0247507, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33690610
7.
Developing and Validating an Effective Pediatric and Adolescent HIV Testing Eligibility Screening Tool for High-Volume Entry Points in Uganda.
J Acquir Immune Defic Syndr;
88(3): 290-298, 2021 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34651604
8.
Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011.
Pan Afr Med J;
29: 191, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30061969
9.
Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy.
Pan Afr Med J;
27: 40, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28761616
10.
From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.
BMC Res Notes;
9(1): 515, 2016 Dec 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28010730
11.
Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
Glob Health Action;
7: 21843, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24433941